Genetics of Frontotemporal Dementia
The three most common genetic causes of frontotemporal dementia are C9orf72 repeat expansions (most common), GRN (progranulin) mutations, and MAPT (microtubule-associated protein tau) mutations, and you should screen for C9orf72 in all possible or probable bvFTD cases regardless of family history. 1
Primary Genetic Mutations
C9orf72 Repeat Expansion
- Most common genetic cause accounting for 13.3% of FTD cases in recent cohorts 2
- Presents with highly variable phenotypes including bvFTD, ALS, or combined presentations 1
- Can manifest initially as psychiatric disorders (bipolar disorder, OCD, schizophrenia) that precede classic FTD symptoms by up to a decade 1
- Severe psychotic symptoms (delusions, auditory hallucinations) occur in 21-56% of carriers—much more prominent than in sporadic FTD 1
- Disease duration can extend up to 22 years with very slow progression in some cases 1
- Critical pitfall: MRI and even FDG-PET can be completely normal at initial assessment 1
GRN (Progranulin) Mutations
- Second most common, accounting for 6.7% of FTD cases 2
- Visual hallucinations and delusions occur in up to 25% of patients and can be the presenting symptom 1
- Strong association with late-onset bipolar disorder type 1 that evolves into bvFTD 1
MAPT Mutations
- Third major genetic cause
- Paranoid delusions and hallucinations described but less common than with C9orf72 or GRN 1
Recommended Genetic Testing Algorithm
Mandatory Testing Scenarios 1
Test all three genes (C9orf72, GRN, MAPT) when:
- Probable bvFTD with at least one first-degree relative with bvFTD, late-onset psychiatric disorder, ALS, or other early-onset neurodegenerative disease
- Family history should be broadly defined to include Parkinson's disease, ALS, and unexplained late-onset psychiatric disorders—not just dementia
Screen C9orf72 in ALL cases of:
Rationale for Broad C9orf72 Screening
The guidelines emphasize C9orf72 screening even without family history because 1:
- Significant proportion of mutations occur in apparent sporadic cases
- Strong overlap with psychiatric phenotypes makes clinical diagnosis challenging
- Genetic testing serves as a diagnostic tool rather than just identifying etiology in clear cases
- Can be justified even in absence of neuroimaging abnormalities
Genetic Contribution by Family History
- Familial FTD: 48% carry pathogenic variants 2
- Sporadic FTD: 11.4% carry pathogenic variants 2
- Overall, genetic mutations account for 26.6% of all FTD-spectrum cases 2
Clinical Red Flags for Genetic FTD
C9orf72-Specific Features
- Severe psychotic symptoms (persecutory, jealousy, grandiosity, religiosity, somatic delusions) 1
- Prodromal psychiatric syndromes preceding behavioral changes by years 1
- Family history of schizophrenia or autism spectrum disorder 1
- Combined FTD-ALS presentation 1
GRN-Specific Features
Important Caveats
Severe psychotic symptoms are a potential marker of genetic abnormality: While psychotic symptoms occur in up to 26% of sporadic FTD, they are much less severe than in C9orf72 carriers and overshadowed by other behavioral changes 1
Pre-test counseling is essential: Patients and families should receive counseling on implications before testing, though access to specialized genetic counselors varies by country 1
Consider whole exome/genome sequencing: For families with multiple affected members (>2) when standard testing is negative 1